235 related articles for article (PubMed ID: 7937975)
1. Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice.
Schwab G; Chavany C; Duroux I; Goubin G; Lebeau J; Hélène C; Saison-Behmoaras T
Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10460-4. PubMed ID: 7937975
[TBL] [Abstract][Full Text] [Related]
2. An approach for new anticancer drugs: oncogene-targeted antisense DNA.
Schwab G; Duroux I; Chavany C; Hélène C; Saison-Behmoaras E
Ann Oncol; 1994; 5 Suppl 4():55-8. PubMed ID: 8060898
[TBL] [Abstract][Full Text] [Related]
3. Short modified antisense oligonucleotides directed against Ha-ras point mutation induce selective cleavage of the mRNA and inhibit T24 cells proliferation.
Saison-Behmoaras T; Tocqué B; Rey I; Chassignol M; Thuong NT; Hélène C
EMBO J; 1991 May; 10(5):1111-8. PubMed ID: 1850694
[TBL] [Abstract][Full Text] [Related]
4. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
[TBL] [Abstract][Full Text] [Related]
5. Antisense properties of end-modified oligonucleotides targeted to Ha-ras oncogene.
Saison-Behmoaras TE; Duroux I; Nguyen TT; Asseline U; Hélène C
Antisense Nucleic Acid Drug Dev; 1997 Aug; 7(4):361-8. PubMed ID: 9303188
[TBL] [Abstract][Full Text] [Related]
6. Activating missense mutations in Ha-ras-1 genes in a malignant subset of bladder lesions induced by N-butyl-N-(4-hydroxybutyl)nitrosamine or N-[4-(5-nitro-2-furanyl)-2-thiazolyl]formamide.
Jones RF; Debiec-Rychter M; Zukowski K; Wang CY
Mol Carcinog; 1990; 3(6):393-402. PubMed ID: 2278634
[TBL] [Abstract][Full Text] [Related]
7. Oligonucleotide treatment of ras-induced tumors in nude mice.
Wickstrom E
Mol Biotechnol; 2001 May; 18(1):35-55. PubMed ID: 11439698
[TBL] [Abstract][Full Text] [Related]
8. The antisense c-Ha-ras oligodeoxynucleotides inhibit the proliferation of the gastrocarcinoma-DNA-transformed rat 3-3 cells and reduce the p21 expression of the cells.
Xu Y; Deng GR; Liang YY; Li C
Sci China B; 1991 Jan; 34(1):35-41. PubMed ID: 2015062
[TBL] [Abstract][Full Text] [Related]
9. Rational design of point mutation-selective antisense DNA targeted to codon 12 of Ha-ras mRNA in human cells.
Duroux I; Godard G; Boidot-Forget M; Schwab G; Hélène C; Saison-Behmoaras T
Nucleic Acids Res; 1995 Sep; 23(17):3411-8. PubMed ID: 7567450
[TBL] [Abstract][Full Text] [Related]
10. [Inhibitory effects of malignant phenotype of human bladder cancer cell line by c-Ha-ras, c-myc antisense oligodeoxynucleotide].
Li M; Yu M; Jin F
Zhonghua Wai Ke Za Zhi; 1996 Jan; 34(1):7-9. PubMed ID: 9275677
[TBL] [Abstract][Full Text] [Related]
11. Antisense inhibition of ras p21 expression that is sensitive to a point mutation.
Chang EH; Miller PS; Cushman C; Devadas K; Pirollo KF; Ts'o PO; Yu ZP
Biochemistry; 1991 Aug; 30(34):8283-6. PubMed ID: 1883816
[TBL] [Abstract][Full Text] [Related]
12. The synthesis and biological activities of oligodeoxynucleotides that are covalently linked to psoralen at their 5' ends.
Wang LX; Yang DC; Lu YY; Takagi Y; Taira K; Li T; Zhang LH
Drug Des Discov; 1995 Nov; 13(2):109-21. PubMed ID: 8872455
[TBL] [Abstract][Full Text] [Related]
13. Antisense oligonucleotides demonstrate a dominant role of c-Ki-RAS proteins in regulating the proliferation of diploid human fibroblasts.
Chen G; Oh S; Monia BP; Stacey DW
J Biol Chem; 1996 Nov; 271(45):28259-65. PubMed ID: 8910444
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of colon cancer cell proliferation by antisense oligonucleotides targeting the messenger RNA of the Ki-ras gene.
Sakakura C; Hagiwara A; Tsujimoto H; Ozaki K; Sakakibara T; Oyama T; Ogaki M; Imanishi T; Yamazaki J; Takahashi T
Anticancer Drugs; 1995 Aug; 6(4):553-61. PubMed ID: 7579559
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitory effect of monoclonal antibody PD4 on Ha-ras transformed cells Rat3-3].
Yin WN
Zhonghua Zhong Liu Za Zhi; 1991 Mar; 13(2):82-6. PubMed ID: 1879298
[TBL] [Abstract][Full Text] [Related]
16. Ha-ras mutations in N-nitrosomorpholine-induced lesions and inhibition of hepatocarcinogenesis by antisense sequences in rat liver.
Baba M; Yamamoto R; Iishi H; Tatsuta M
Int J Cancer; 1997 Sep; 72(5):815-20. PubMed ID: 9311599
[TBL] [Abstract][Full Text] [Related]
17. Antisense PNA tridecamers targeted to the coding region of Ha-ras mRNA arrest polypeptide chain elongation.
Dias N; Dheur S; Nielsen PE; Gryaznov S; Van Aerschot A; Herdewijn P; Hélène C; Saison-Behmoaras TE
J Mol Biol; 1999 Nov; 294(2):403-16. PubMed ID: 10610767
[TBL] [Abstract][Full Text] [Related]
18. Growth inhibition of human pancreatic cancer cell lines by anti-sense oligonucleotides specific to mutated K-ras genes.
Kita K; Saito S; Morioka CY; Watanabe A
Int J Cancer; 1999 Feb; 80(4):553-8. PubMed ID: 9935156
[TBL] [Abstract][Full Text] [Related]
19. Antisense inhibition of protein kinase Calpha reverses the transformed phenotype in human lung carcinoma cells.
Wang XY; Repasky E; Liu HT
Exp Cell Res; 1999 Jul; 250(1):253-63. PubMed ID: 10388539
[TBL] [Abstract][Full Text] [Related]
20. [Oligonucleotides complementary to the mRNA of the c-HA-ras gene suppress human cell proliferation in culture].
Debus N; Griaznov SM; Berdichevskiĭ FB
Dokl Akad Nauk SSSR; 1990; 313(2):491-4. PubMed ID: 2289400
[No Abstract] [Full Text] [Related]
[Next] [New Search]
